INFLUENZA VACCINE
Clinical trials for INFLUENZA VACCINE explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA VACCINE trials appear
Sign up with your email to follow new studies for INFLUENZA VACCINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New flu vaccine for seniors passes first safety check
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing whether a new flu vaccine with an adjuvant (a booster ingredient) is safe for adults aged 65 and older. Eighty volunteers will receive a single shot and be monitored for side effects over a year. The study does not yet test if the vaccine prevent…
Matched conditions: INFLUENZA VACCINE
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:06 UTC
-
New flu vaccine for seniors enters safety testing
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing the safety of a new quadrivalent influenza vaccine with an adjuvant (a booster ingredient) in adults aged 65 and older. Eighty participants will receive either the new vaccine, a standard flu vaccine, or a placebo. The study monitors side effects…
Matched conditions: INFLUENZA VACCINE
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:05 UTC
-
Why do flu shots weaken with age? new study aims to find out
Knowledge-focused OngoingThis study follows 75 adults aged 65 and older over three to four flu seasons to learn why the flu vaccine becomes less effective as people age. Participants will receive a different FDA-approved flu vaccine each year, and researchers will collect blood, nasal swab, and stool sam…
Matched conditions: INFLUENZA VACCINE
Phase: PHASE4 • Sponsor: The Jackson Laboratory • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC